Macopharma, 2026-11-21: Manufacturer page for the methylene blue plasma pathogen-reduction set, describing the process (MB pill 85 micrograms, illumination, Blueflex removal filter) and its virus claims.
A user-friendly and effective pathogen inactivation technique against enveloped and non-enveloped viruses designed for single units of plasma
Macopharma, 2026-11-21: Manufacturer page for the methylene blue plasma pathogen-reduction set, describing the process (MB pill 85 micrograms, illumination, Blueflex removal filter) and its virus claims. Manufacturer: Macopharma, France. Each set uses an 85 microgram anhydrous methylene blue chloride pill for 235-330 mL plasma, illumination, then a Blueflex filter to remove MB and photoproducts. document_date is the access date (page undated). Archive capture 2026-07-10. Study type: other.
